Jump to content

RX - Biosyent


jm25

Recommended Posts

  • 2 weeks later...
  • Replies 201
  • Created
  • Last Reply

Top Posters In This Topic

Top Posters In This Topic

Posted Images

LOL - I was following it all the way down to 3.30 in early Feb ... note to self - when there is a massive drop in price in a company where Klarman has a large stake .... BUY

 

Klarman?

Link to comment
Share on other sites

Watching the stock rise up so much every day is exciting and all, but could it be possible that the stock is starting to reach levels that don't support the fundamentals?

 

What do you guys think?

 

It's possible and probably even likely BUT it is really impossible to value a company growing this quickly. Rather than trying to find a target price, you need to be thinking about how sustainable this growth is. Once the growth slows, the multiple will be hit but it could easily be worth 10x by then.

Link to comment
Share on other sites

Let me write it short. If 50 M$ sales = 20 $ stock price.

 

I don't know when ... Maybe 5-7-8 years from now, it is a long road from 10 M$ ! The IF is the most important word here !

 

 

 

If they have to make 400% more sales for you to make 150% on your stock...dont you think you should sell?

Link to comment
Share on other sites

Let me write it short. If 50 M$ sales = 20 $ stock price.

 

I don't know when ... Maybe 5-7-8 years from now, it is a long road from 10 M$ ! The IF is the most important word here !

 

 

 

If they have to make 400% more sales for you to make 150% on your stock...dont you think you should sell?

I appreciate the friendly way you ask the question. The company is still very small and a lot of growth to come, but I dare not compare with Paladin Lab. Especially on a value investor  forum :)

 

For a full response, I encourage you to use the Benjamin Graham Intrinsic Value Formula

 

http://www.joshuakennon.com/benjamin-graham-intrinsic-value-formula/

 

After you get the Intrinsic value, I would know your opinion.

 

Thanks

 

Snow

Link to comment
Share on other sites

https://secure.marketwatch.com/story/biosyent-pharma-receives-health-canada-approval-to-market-new-urgent-care-product-2014-06-12

 

BioSyent Inc. is pleased to announce that its subsidiary BioSyent Pharma Inc. has received Health Canada - Therapeutics Products Directorate approval to market a new urgent care product. This is the first of two products that were in-licensed from a European partner and submitted to Health Canada in 2013 for approval.

 

The newly approved urgent care drug is supplied in a patented delivery system that offers technical advantages over existing alternatives and will be used in hospitals and acute care settings. These products will provide hospitals, clinics, and healthcare professionals with improved patient safety as well as operational efficiencies and will be marketed by BioSyent Pharma's Hospital Division. It is anticipated that this new product will be launched in late 2014 or early 2015. "In anticipation of Health Canada approval our commercial team has started the launch preparation process for this new product," said Rene Goehrum, President and CEO of BioSyent. "We have already started discussions with key opinion leaders and other decision makers in the Canadian hospital market." Further product details will be disclosed closer to the launch date.

Link to comment
Share on other sites

  • 1 month later...

Announced last friday, RX will be add to TSX-V index july 21. Points from Rene Goehrum CEO at Bloom Burton Conference:

 

Active in-licensing (new product) deal funnel – to support > 30% Revenue CAGR 2014-2018 !

 

7 marketed products by Q2 2015... won't be a big surprise if they growth 50 % over next 12 months

 

 

 

Link to comment
Share on other sites

  • 2 weeks later...

 

 

I think in a previous presentation they mentioned partnering internationally.

 

http://microcapclub.com/2013/02/microcapclub-invitational-biosyent-rx-v/

 

@27:00 (presentation was from Feb 2013)

 

From 2014 Q1 MD&A, page 4:

 

The company is investigating out-licencing opportunities for the sale and distribution of FeraMAX 150 and Powder brands in international markets.. To-date one international customer has commenced marketing Feramax 150 and has purchased 1.23 million doses in two separate shipments Q2 2013 and Q1 2014

Link to comment
Share on other sites

I don't have info about Riso competitive advantage

    ----------------------

"Riso Pharma Tech is a Canadian-based affiliate of a large Holding Company, Riso Holding. As a group, Riso has sole agency agreements with some of the largest pharmaceutical companies in the world for Middle Eastern market. Riso is also a provider of medicinal products and health care supplements serving dedicated markets world-wide, but focusing on the Middle East, North Africa and Latin America."

Link to comment
Share on other sites

  • 2 weeks later...

Biosyent looks to have a partnership with a company from Italia with close to 40 products portfolio.

 

Farma Derma

 

http://www.farmaderma.com/index.php?option=com_content&view=article&id=8&Itemid=114

 

http://www.repagyn.ca

 

As Rx will have 9 products marketed soon (8 Q2 + 1 after), it will be interesting to see if they could reach a large portfolio as Paladin lab.

Link to comment
Share on other sites

 

 

I think in a previous presentation they mentioned partnering internationally.

 

http://microcapclub.com/2013/02/microcapclub-invitational-biosyent-rx-v/

 

@27:00 (presentation was from Feb 2013)

 

From 2014 Q1 MD&A, page 4:

 

The company is investigating out-licencing opportunities for the sale and distribution of FeraMAX 150 and Powder brands in international markets.. To-date one international customer has commenced marketing Feramax 150 and has purchased 1.23 million doses in two separate shipments Q2 2013 and Q1 2014

 

Q2-net income + 125 %. Be patient, this company is going higher...

 

 

https://docs.google.com/viewer?a=v&pid=sites&srcid=ZGVmYXVsdGRvbWFpbnxiaW9zeWVudHxneDo3ZTI4ZmNkMTI3NGY3ZDFj

https://docs.google.com/viewer?a=v&pid=sites&srcid=ZGVmYXVsdGRvbWFpbnxiaW9zeWVudHxneDo3ZTI4ZmNkMTI3NGY3ZDFj

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now



×
×
  • Create New...